A Long-Term Survival Case of Primary Angiosarcoma
in Liver Treated with Weekly Docetaxel Chemotherapy |
A Long-Term Survival Case of Primary Angiosarcoma in Liver Treated with Weekly Docetaxel Chemotherapy |
Sun Kyung Park; Jin Young Kim; Jung Min Lee; Gang Guk Lee; Young Rok Do; Keon Uk Park; Hong Suk Song |
|
|
Abstract |
Angiosarcoma is rare malignant endothelial cell tumor of vascular or lymphatic origin. It may
occur in any region of the body; but more frequent in skin and soft tissue. Though hepatic
angiosarcoma is rare primary tumor of the liver; it is the third most common primary malignant
tumor of the liver. Treatment options for hepatic angiosarcoma are limited; and they depend
mainly on the stage of the disease during diagnosis. We report a rare case of primary
angiosarcoma of the liver. We treated our patient with weekly docetaxel chemotherapy regimen.
She received a total of six cycles without disease progression or unendurable toxicity occurred;
and had long-term survival fourteen months after the diagnosis. An effective treatment for
hepatic angiosarcoma has not yet been established. Chemotherapy with docetaxel should be
considered in the treatment of patients with primary angiosarcoma of the liver. |
Key Words:
Angiosarcoma, Docetaxel,
Liver |